(Moe A, Liphart HA, Heaster K, Romero J, Drobyski WR, Hillard CJ.) Cannabis Cannabinoid Res. 2026 Aug;11(4):324-334 PMID: 41958320 04/10/2026
— 2026cited by 0position: selected
(Leddy RS, Hudachek CL, Phelan HM, Aherne CM, Romero J, Hillard CJ, Wang Z, Eissner G, Jedlicka P, Collins CB.) Inflamm Bowel Dis. 2026 May 14 PMID: 42133571 05/14/2026
— 2026cited by 0position: selected
(Aughey E, Shah NN, Hillard CJ, Rentscher KE, Hamadani M, Longo W, Devata S, Knight JM, Cusatis R.) Transplant Cell Ther. 2026 May;32(5):621.e1-621.e11 PMID: 41485560 PMCID: PMC12952239 SCOPUS ID: 2-s2.0-105029718493 01/05/2026
— 2026cited by 0position: selected
(Kelly TJ, Liu X, Huang Y, Hu Y, Friedman V, Hillard CJ, Liu QS.) Nat Commun. 2026 Apr 08;17(1) PMID: 41951611 PMCID: PMC13237297 SCOPUS ID: 2-s2.0-105041012167 04/09/2026
— 2026cited by 0position: selected
(Estes MK, Guda V, Thompson E, de Oliveira DR, Nowak DB, Hillard CJ, Mantsch JR.) Psychopharmacology (Berl). 2026 Feb 21 PMID: 41721858 02/21/2026
— 2026cited by 0position: selected
(Albertina EA, Tomas CW, Geier TJ, Timmer-Murillo SC, Pina IG, Jazinski-Chambers K, Sauber G, Fitzgerald JM, Larson CL, deRoon-Cassini TA, Hillard CJ.) Psychopharmacology (Berl). 2026 Feb;243(2):383-399 PMID: 40643612 PMCID: PMC12904968 SCOPUS ID: 2-s2.0-105010584798 07/11/2025
— 2026cited by 0position: selected
(Ruiz de Martín Esteban S, Grande MT, Martínez-Relimpio AM, Herráez-Aguilar D, Mostany R, Hillard CJ, Hind WH, Romero J.) Biomed Pharmacother. 2026 Jan;194:118902 PMID: 41389629 SCOPUS ID: 2-s2.0-105024468467 12/14/2025
— 2026cited by 0position: selected
Physical Activity Is Positively Associated with Model-Based Decision-Making in Pursuit of Reward in Trauma-Exposed Adults
(Albertina EA, Torres L, Sauber G, Hillard CJ, Fitzgerald JM, deRoon-Cassini TA, Larson CL.) Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 Sep 26 PMID: 41016700 PMCID: PMC12857617 SCOPUS ID: 2-s2.0-105029632280 09/29/2025
— 2025cited by 0position: selected
(Marusak HA, Zundel CG, Shakir T, Ely SL, Carpenter C, Shampine M, Tamimi R, Matsko M, Rogers S, Losiowski J, O'Mara E, Jaster AM, Sharma K, deRoon-Cassini TA, Hillard CJ, Schroeder HK, Mills JA, Strawn JR, Barcelona J.) Neuropsychopharmacology. 2025 Sep;50(10):1606-1614 PMID: 40579470 PMCID: PMC123
— 2025cited by 0position: selected
(Wallace AL, Baca R, Andrade G, Hillard CJ, Happer JP, Wade NE, Courtney KE, Mejia MH, Jacobus J.) Front Adolesc Med. 2025;3 PMID: 41257091 PMCID: PMC12622566 11/19/2025
— 2025cited by 0position: selected
(Chelimsky G, Conant L, Simpson P, Zhang L, Marchand S, Hillard C, Chelimsky T.) Pain Reports. 16 June 2025;10(4):e1273 SCOPUS ID: 2-s2.0-105008981390 06/16/2025
— 2025cited by 0position: selected
Detection of cannabinoid receptor type 2 in native cells and zebrafish with a highly potent, cell-permeable fluorescent probe
Editorial: Therapeutic potential of the cannabinoid CB2 receptor
The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill
The Lateral Habenula Directs Coping Styles Under Conditions of Stress via Recruitment of the Endocannabinoid System
Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol
The endocannabinoid system in guarding against fear, anxiety and stress
Mechanisms of Exercise-Induced Hypoalgesia
Circadian Rhythm of Circulating Levels of the Endocannabinoid 2-Arachidonoylglycerol
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans
Disruption of fatty acid amide hydrolase activity prevents the effects of chronic stress on anxiety and amygdalar microstructure
Circulating Endocannabinoid Concentrations and Sexual Arousal in Women